The FDA gives the green light to the first gene therapy for deafness

Source: NPR Topics: News · Bias: Center

Summary

The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.

Related Coverage

Daily Analysis

Read the full Parallax Pulse for April 23, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.

More Headlines From April 23, 2026

The FDA gives the green light to the first gene therapy for deafness
NPR Topics: News

The FDA gives the green light to the first gene therapy for deafness

Center

The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.